Sunitinib: In Advanced, Well Differentiated Pancreatic Neuroendocrine Tumors

ISSN： 1173-8804

Source： BioDrugs, Vol.25, Iss.5, 2011-10, pp. : 307-316

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Exploratory Factor Analysis of the 12-Item Functional Assessment of Chronic Illness Therapy–Spiritual Well-Being Scale in People Newly Diagnosed With Advanced Cancer

By Bai Mei Dixon Jane K.

Journal of Nursing Measurement, Vol. 22, Iss. 3, 2014-12 ,pp. : 404-420

Springer Publishing Company

Access to resources Recommend Favorite

Neuroendocrine and Immune Aspects of Fibromyalgia

By van West D. Maes M.

BioDrugs, Vol. 15, Iss. 8, 2001-08 ,pp. : 521-531

Adis International

Access to resources Recommend Favorite

Pancreatic cancer

Journal of Pain Management, Vol. , Iss. , 2017-01 ,pp. : 33-32

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Sunitinib: A Multitargeted Receptor Tyrosine Kinase Inhibitor in the Era of Molecular Cancer Therapies

By Papaetis Georgios S. Syrigos Kostas N.

BioDrugs, Vol. 23, Iss. 6, 2009-12 ,pp. : 377-389

Adis International

Access to resources Recommend Favorite

Editorial: Measuring Well to Study Well

By STRICKLAND ORA

Journal of Nursing Measurement, Vol. 1, Iss. 1, 1993-01 ,pp. : 3-4

Springer Publishing Company

Access to resources Recommend Favorite